Dendritic cell mediated modulation of tolerance by apoptotic cells in aged humans

树突状细胞介导老年人凋亡细胞对耐受性的调节

基本信息

  • 批准号:
    7148765
  • 负责人:
  • 金额:
    $ 18.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-01 至 2008-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant: Aged humans are more susceptible to infections and cancer as a consequence of progressive decline in immune functions with aging. Paradoxically, this decline in immune function is associated with increased reactivity towards self or endogenous antigens. There is increased autoantibody production and propensity towards developing autoimmune diseases with age. This suggests a loss of self tolerance associated with immunosenescence. Amongst the cells of the immune system, dendritic cells are the most potent of antigen presenting cells that are critical mediators of both tolerance and immunity. Immature dendritic cells constantly sample antigens from dying cells in the periphery and present them to T cells in the absence of costimulation, leading to T cell tolerance. Uptake and ingestion of apoptotic cells by dendritic cells is thus considered to be one of the major mechanisms responsible for peripheral self tolerance. Apoptosis is increased in aged humans and during apoptosis, nuclear antigens are expressed on cell membranes and may serve to induce autoreactivity if apoptotic cells are not swiftly and efficiently cleared. Our preliminary data suggest that dendritic cells in aging display a more mature phenotype and reduced uptake of apoptotic cells compared to their young counterparts. Therefore our hypothesis is that the peripheral tolerance inducing capacity of dendritic cells is altered with age and plays a major role in increased autoimmunity associated with aging. The following are the specific aims of the project- 1) to determine the mechanisms for impaired uptake of apoptotic cells in human monocyte- derived dendritic cells with age. 2) to analyze a role of dendritic cells in age-associated alterations in the induction and maintenance of peripheral tolerance.
描述(申请人提供:由于免疫功能随着年龄的增长逐渐下降,老年人更容易受到感染和癌症的影响。矛盾的是,这种免疫功能的下降与对自身或内源性抗原的反应性增加有关。随着年龄的增长,自身抗体的产生和发生自身免疫性疾病的倾向都会增加。这表明与免疫衰老相关的自我耐受性丧失。在免疫系统的细胞中,树突状细胞是最有效的抗原提呈细胞,是免疫耐受和免疫的关键介质。未成熟的树突状细胞不断地从外周死亡的细胞中提取抗原,并在没有共刺激的情况下将它们呈递给T细胞,导致T细胞耐受。树突状细胞对凋亡细胞的摄取和摄取被认为是导致外周自身耐受的主要机制之一。老年人的细胞凋亡率增加,在细胞凋亡期间,核抗原在细胞膜上表达,如果不能迅速有效地清除凋亡的细胞,可能会诱导自身反应。我们的初步数据表明,与年轻的树突状细胞相比,衰老的树突状细胞表现出更成熟的表型,并减少了对凋亡细胞的摄取。因此,我们的假设是,树突状细胞的外周耐受诱导能力随着年龄的增加而改变,并在与年龄相关的自身免疫增强中发挥主要作用。以下是该项目的具体目标-1)确定人类单核细胞来源的树突状细胞随年龄增长而对凋亡细胞的摄取受损的机制。2)分析树突状细胞在诱导和维持外周免疫耐受中与年龄相关的改变中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anshu Agrawal其他文献

Anshu Agrawal的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anshu Agrawal', 18)}}的其他基金

Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
  • 批准号:
    10696138
  • 财政年份:
    2022
  • 资助金额:
    $ 18.76万
  • 项目类别:
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
前列腺癌中种族决定的 T 细胞反应和 GARP/TGFbeta1 信号传导
  • 批准号:
    10358338
  • 财政年份:
    2021
  • 资助金额:
    $ 18.76万
  • 项目类别:
Ethnicity-determined T cell responses and GARP/TGFbeta1 signaling in prostate cancer
前列腺癌中种族决定的 T 细胞反应和 GARP/TGFbeta1 信号传导
  • 批准号:
    10538647
  • 财政年份:
    2021
  • 资助金额:
    $ 18.76万
  • 项目类别:
Impaired ability of aged human dendritic cells to maintain mucosal tolerance
衰老的人类树突状细胞维持粘膜耐受性的能力受损
  • 批准号:
    8694995
  • 财政年份:
    2014
  • 资助金额:
    $ 18.76万
  • 项目类别:
Impaired ability of aged human dendritic cells to maintain mucosal tolerance
衰老的人类树突状细胞维持粘膜耐受性的能力受损
  • 批准号:
    8927521
  • 财政年份:
    2014
  • 资助金额:
    $ 18.76万
  • 项目类别:
Dendritic cell mediated modulation of tolerance by apoptotic cells in aging
树突状细胞介导衰老过程中凋亡细胞对耐受性的调节
  • 批准号:
    7268013
  • 财政年份:
    2006
  • 资助金额:
    $ 18.76万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 18.76万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 18.76万
  • 项目类别:
Assessing the impact of acquired immunodeficiency on congenital Zika virus
评估获得性免疫缺陷对先天性寨卡病毒的影响
  • 批准号:
    10176384
  • 财政年份:
    2018
  • 资助金额:
    $ 18.76万
  • 项目类别:
Assessing the impact of acquired immunodeficiency on congenital Zika virus
评估获得性免疫缺陷对先天性寨卡病毒的影响
  • 批准号:
    10412099
  • 财政年份:
    2018
  • 资助金额:
    $ 18.76万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 18.76万
  • 项目类别:
Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS
人类免疫缺陷病毒 (HIV)/获得性免疫缺陷病毒综合症 (艾滋病)
  • 批准号:
    8600940
  • 财政年份:
    2013
  • 资助金额:
    $ 18.76万
  • 项目类别:
Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome AIDS
人类免疫缺陷病毒 (HIV)/获得性免疫缺陷病毒综合症 艾滋病
  • 批准号:
    8522015
  • 财政年份:
    2013
  • 资助金额:
    $ 18.76万
  • 项目类别:
Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS
人类免疫缺陷病毒 (HIV)/获得性免疫缺陷病毒综合症 (艾滋病)
  • 批准号:
    8522532
  • 财政年份:
    2013
  • 资助金额:
    $ 18.76万
  • 项目类别:
HUMAN IMMUNODEFICIENCY VIRUS (HIV) ACQUIRED IMMUNODEFICIENCY VIRUS SYNDROME AIDS)
人类免疫缺陷病毒 (HIV) 获得性免疫缺陷病毒综合症 (艾滋病)
  • 批准号:
    8599397
  • 财政年份:
    2013
  • 资助金额:
    $ 18.76万
  • 项目类别:
Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome AIDS
人类免疫缺陷病毒 (HIV)/获得性免疫缺陷病毒综合症 艾滋病
  • 批准号:
    8600919
  • 财政年份:
    2013
  • 资助金额:
    $ 18.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了